Welcome to the Shoichet Lab
"Our research program requires a cross disciplinary approach where aspects of engineering, chemistry, and biology are applied to the fields of Regenerative Medicine, Tissue Engineering and Drug Delivery. We approach unsolved problems in medicine by creating a series of design criteria which we then use to formulate solutions."
Ontario Chief Scientist Dr. @MollyShoichet & her team (@ShoichetLab @UofT) are engineering new materials to help restore vision to people who lose their sight from diseases like age-related #maculardegeneration. Just 1 of the amazing ways #WeAreOntarioInnovation pic.twitter.com/KXaLSe1f3t
— OntarioInnovation (@OntInnovation) April 19, 2018
The Numbers
Features
Feature of the Month: April 2019
Congratulations to Dr. Alexander Baker who successfully defended his PhD!We also wish to congratulate Alexander Baker on winning the best poster award in the Health area at the Chem Eng dinner! Welcome Dr. Muhammad Rizwan as a post-doctoral fellow to our lab!
Read more
International Union of Pure and Applied Chemistry
On February 7, 2019, the International Union of Pure and Applied Chemistry (IUPAC) named Dr. Molly Shoichet a 2019 Distinguished Woman in Chemistry or Chemical Engineering. International Union of Pure and Applied Chemistry Chemical Engineering News Chemistry and Industry (April 2019)
Read more
University Affairs
The February 1, 2019 issue of University Affairs, features Dr. Molly Shoichet. Undeterred from any losses that may come her way, one constant goal that pushes Dr. Shoichet forward is to be a champion of science.
Read more
AmacaThera
AmacaThera, a Toronto-based company commercializing hydrogel-based drug delivery platforms, has raised $3.25 million CAD in seed financing from Sprout BioVentures, Viva Biotech, and Grey Sky Venture Partners. AmacaThera’s founding technology was discovered at the University of Toronto by Dr. Molly Shoichet, a leading expert on polymer design. AmacaThera envisions their proprietary…
Read more
Recent Publications
Publication
“Colloidal drug aggregate stability in high serum conditions and pharmacokinetic consequence” Ganesh AN; Aman A; Logie J; Barthel BL; Cogan P; Al-awar RS; Koch TH; Shoichet BK; Shoichet MS. 2019 ACS Chemical Biology, in press, xx1-xx7; doi: 10.1021/acschembio.9b00032 Publication
Read more
Publication
“Local delivery of stabilized chondroitinase ABC degrades chondroitin sulfate proteoglycans in stroke-injured rat brains” Hettiaratchi MH; O’Meara MJ; Teal CJ; Payne SL; Pickering AJ; Shoichet MS. 2019 J.Controlled Release, 297: 14-25; doi: 10.1016/j.jconrel.2019.01.033 Publication
Read more
Publication
“Local delivery of BDNF enables behavioural recovery and tissue repair in stroke-injured rats” Obermeyer JM; Tuladhar A; Payne SL; Ho E; Morshead CM; Shoichet MS. 2019 Tissue Engineering, Part A., accepted 11/30/2018; doi: 10.1089/ten.TEA.2018.0215
Read more
Publication
“Controlled release strategy designed for intravitreal protein delivery to the retina” Delplace V; Ortin-Martinez A; Tsai ELS; Amin AN; Wallace V; Shoichet MS. 2019, J.Controlled Release, 293: 10-20; doi: 10.1016/j.jconrel.2018.11.012 Publication
Read more
